Business Description
Observe Medical ASA
ISIN : NO0013457952
Share Class Description:
STU:OM50: Ordinary SharesTotal Employee Number:
5Description
Observe Medical ASA is a Nordic medtech company focused on the development, commercialization, and scaling of medical technologies for the healthcare markets. The company's portfolio of proprietary products consists of: Sippi, a CE marked digitalized system for urine output measurement, the UnoMeter portfolio consisting of manual urine output measurement products and solutions for measuring intra-abdominal pressure. The company operates internationally through subsidiaries in Norway, Sweden and Denmark.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.19 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 1.44 | |||||
Debt-to-EBITDA | -3.57 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -0.84 | |||||
Beneish M-Score | -4.21 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -55.1 | |||||
3-Year EBITDA Growth Rate | 57.1 | |||||
3-Year EPS without NRI Growth Rate | 95.2 | |||||
3-Year FCF Growth Rate | 64.9 | |||||
3-Year Book Growth Rate | -77.5 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.04 | |||||
9-Day RSI | 47.29 | |||||
14-Day RSI | 47.35 | |||||
3-1 Month Momentum % | 2.84 | |||||
6-1 Month Momentum % | -0.8 | |||||
12-1 Month Momentum % | 26.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.47 | |||||
Quick Ratio | 0.33 | |||||
Cash Ratio | 0.22 | |||||
Days Inventory | 127.93 | |||||
Days Sales Outstanding | 23.51 | |||||
Days Payable | 343.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -167.4 | |||||
Shareholder Yield % | 34.59 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 27.35 | |||||
Operating Margin % | -68.71 | |||||
Net Margin % | -109.68 | |||||
EBITDA Margin % | -54.17 | |||||
FCF Margin % | -189.43 | |||||
OCF Margin % | -182.05 | |||||
ROE % | -114.44 | |||||
ROA % | -22.02 | |||||
ROIC % | -12.43 | |||||
3-Year ROIIC % | -15.63 | |||||
ROC (Joel Greenblatt) % | -29549.28 | |||||
ROCE % | -34.41 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio without NRI | 5.58 | |||||
PEG Ratio | 0.14 | |||||
PS Ratio | 5.78 | |||||
PB Ratio | 4.55 | |||||
EV-to-EBIT | -8.17 | |||||
EV-to-EBITDA | -14.17 | |||||
EV-to-Revenue | 7.68 | |||||
EV-to-FCF | -3.99 | |||||
Price-to-GF-Value | 4.03 | |||||
Earnings Yield (Greenblatt) % | -12.24 | |||||
FCF Yield % | -31.51 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Observe Medical ASA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1.939 | ||
| EPS (TTM) (€) | -0.018 | ||
| Beta | -0.5734 | ||
| 3-Year Sharpe Ratio | 0.08 | ||
| 3-Year Sortino Ratio | 0.11 | ||
| Volatility % | 80.46 | ||
| 14-Day RSI | 47.35 | ||
| 14-Day ATR (€) | 0.008635 | ||
| 20-Day SMA (€) | 0.08081 | ||
| 12-1 Month Momentum % | 26.72 | ||
| 52-Week Range (€) | 0.041 - 0.119 | ||
| Shares Outstanding (Mil) | 136.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Observe Medical ASA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Observe Medical ASA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Fourth quarter earnings results for 2026 | 2027-02-26 | In 180 days | ||
| Fourth quarter earnings conference call for 2026 | 2027-02-26 | In 180 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-25 | 0.09 (+8.15%) | ||
| Second quarter earnings results for 2026 | 2026-08-25 | 0.09 (+8.15%) | ||
| General meeting for 2025 | 2026-05-29 10:00 | 0.08 (-2.31%) | ||
| Annual report for 2025 | 2026-04-30 | 0.09 (-1.05%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-27 | 0.08 (-7.27%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-27 | 0.08 (-7.27%) | ||
| Second quarter earnings results for 2025 | 2025-08-22 | 0.08 (+25.98%) | ||
| General meeting for 2024 | 2025-06-27 10:00 | 0.06 (+3.33%) |
Show
Entries
Observe Medical ASA Frequently Asked Questions
What is Observe Medical ASA(STU:OM50)'s stock price today?
The current price of STU:OM50 is €0.08. The 52 week high of STU:OM50 is €0.12 and 52 week low is €0.04.
When is next earnings date of Observe Medical ASA(STU:OM50)?
The next earnings date of Observe Medical ASA(STU:OM50) is 2027-02-26 Est..
Does Observe Medical ASA(STU:OM50) pay dividends? If so, how much?
Observe Medical ASA(STU:OM50) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Observe Medical ASA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers